Mylan launches antifungal drug

PITTSBURGH — Mylan has launched a generic drug for treating fungal infections, the drug maker said Friday.



Mylan announced the launch of itraconazole capsules in the 100-mg strength. The drug is a generic version of Johnson & Johnson's Sporanox, which is used to treat fungal infections that begin in the lungs blatsomycosis, histoplasmosis and aspergillosis in patients who are intolerant of or refractory to amphotericin B therapy. The drug also is used to treat fungal infections in the toenails and fingernails in patients without compromised immune systems.



The drug had sales of about $60 million during the 12-month period ended in March, according to IMS Health.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.